Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in SGMT — Sagimet Biosciences Inc.

CIK 1595888 NEW YORK, NY
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$89,800 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Derivatives in SGMT

reported options exposure · as of Jun 30, 2026
CallValue
$112,858
CallShares
14,600
PutValue
$411,236
PutShares
53,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in SGMT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $112,858 14,600
2026-06-30 $411,236 53,200
2026-03-31 $387,172 74,100
2026-03-31 $89,800 17,187
2025-12-31 $547,220 92,436
2025-12-31 $495,504 83,700
2025-09-30 $344,372 50,200
2025-09-30 $88,089 12,841
2025-06-30 $216,408 28,400
2025-06-30 $1,274,826 167,300
2025-06-30 $181,302 23,793
2025-03-31 $35,534 10,900
2025-03-31 $90,842 27,866
2024-12-31 $248,732 55,274
2024-06-30 $518,581 151,632
2024-03-31 $129,743 23,938